SYNTHESIS, RADIOSYNTHESIS AND INITIAL BIOLOGICAL EVALUATION OF A NEW CLASS OF CANDIDATE BRAIN CANNABINOID TYPE-1 (CB1) RECEPTOR RADIOLIGAND

被引：0
|
作者：
Donohue, S. [1 ,2 ]
Halldin, C. [2 ]
Brown, A. [1 ]
Hong, J. [1 ]
Musachio, J. L. [1 ]
Bacher, J. [3 ]
Innis, R. B. [1 ]
Pike, V. W. [1 ]
机构：
[1] NIMH, Mol Imaging Branch, Bethesda, MD 20892 USA
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2005年 / 48卷
关键词：
CB1; Recptor; PET; Diarylpyrazolines;
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [41] Immunohistochemical distribution of cannabinoid receptor type 1 (CB1) and type 2 (CB2) in the rat carotid body
    Saito, Hiroki
    Yokoyama, Takuya
    Nakamuta, Nobuaki
    Yamamoto, Yoshio
    ACTA HISTOCHEMICA, 2024, 126 (08)
  • [42] Novel Method for Synthesis of Diarylpyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Wu Ying-qiu
    Zheng Guo-jun
    Wang Ya-ping
    Wang Xiang-jing
    Xiang Wen-sheng
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2011, 27 (01) : 66 - 69
  • [43] Cell-Type Specific Alterations in Cannabinoid Receptor 1 (CB1) in Patients With Schizophrenia
    Chou, Shinnyi
    Fish, Kenneth
    Lewis, David
    Sweet, Robert
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 326 - 326
  • [44] BRAIN FAS/FADD DEATH RECEPTOR COMPLEX IN CANNABINOID CB1 RECEPTOR KNOCKOUT MICE
    Alvaro-Bartolome, M.
    Esteban, S.
    Valverde, O.
    Garcia-Sevilla, J. A.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 82 - 82
  • [45] NEURONAL CONTROL OF MICTURITION VIA CANNABINOID (CB) TYPE 1 RECEPTORS - EVALUATION OF A CB1 KNOCKOUT MOUSE
    Fuellhase, Claudius
    Campeau, Lysanne
    Sibaev, Andrei
    Storr, Martin
    Gratzke, Christian
    Stief, Christian
    Hedlund, Petter
    Andersson, Karl-Erik
    JOURNAL OF UROLOGY, 2013, 189 (04): : E48 - E49
  • [46] Synthesis and structure-activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB1) receptor ligands for potential use in molecular imaging
    Donohue, SR
    Halldin, C
    Pike, VW
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (11) : 3712 - 3720
  • [47] CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
    Teixeira-Clerc, Fatima
    Julien, Boris
    Grenard, Pascale
    Van Nhieu, Jeanne Tran
    Deveaux, Vanessa
    Li, Liying
    Serriere-Lanneau, Valerie
    Ledent, Catherine
    Mallat, Ariane
    Lotersztajn, Sophie
    NATURE MEDICINE, 2006, 12 (06) : 671 - 676
  • [48] Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
    Le Foll, B
    Goldberg, SR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 875 - 883
  • [49] Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: Regulation by hydrocortisone
    Rice, W
    Shannon, JM
    Burton, F
    Fiedeldey, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 327 (2-3) : 227 - 232
  • [50] CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
    Fatima Teixeira-Clerc
    Boris Julien
    Pascale Grenard
    Jeanne Tran Van Nhieu
    Vanessa Deveaux
    Liying Li
    Valérie Serriere-Lanneau
    Catherine Ledent
    Ariane Mallat
    Sophie Lotersztajn
    Nature Medicine, 2006, 12 : 671 - 676
12345